# Navigated αTMS in Treatment-resistant Schizophrenia

> **NCT01941251** · NA · UNKNOWN · sponsor: **Niuvanniemi Hospital** · enrollment: 50 (actual)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorder

## Interventions

- **DEVICE:** navigated Transcranial Magnetic Stimulation
- **DEVICE:** navigated Transcranial Magnetic Stimulation

## Key facts

- **NCT ID:** NCT01941251
- **Lead sponsor:** Niuvanniemi Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-03
- **Primary completion:** 2016-03
- **Final completion:** 2025-12
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2023-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01941251

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01941251, "Navigated αTMS in Treatment-resistant Schizophrenia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01941251. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*